FDA adds a warning to Covid-19 vaccines about risk of heart inflammation

▴ fda_adds_a_warning_to_covid-19_vaccines_medicircle
FDA say benefits outweigh the heart problem risks

The US Food and Drug Administration added a warning about the risk of myocarditis and pericarditis to fact sheets for Moderna and Pfizer-BioNTech Covid-19 vaccines Friday.

The warning notes that reports of adverse events following vaccination -- particularly after the second dose -- suggest increased risks of both types of heart inflammation.

Earlier this week, vaccine advisers to the US Centers for Disease Control and Prevention heard that the agency had received about 1,200 reports of such heart inflammation after 300 million doses of the two vaccines had been given. CDC has confirmed about 300 of those cases, many of them among young men and adolescents.

But patients are recovering quickly, Dr Matthew Oster, a pediatric cardiologist, told the advisers.

The FDA is advising vaccine recipients to seek immediate medical attention if they experience "chest pain, shortness of breath, or feelings of having a fast-beating, fluttering, or pounding heart after vaccination."

"This update follows an extensive review of information and the discussion by CDC's Advisory Committee on Immunization Practices meeting on Wednesday," the FDA said.

"The data presented at this meeting reinforced the FDA's decision to revise the fact sheets and further informed the specific revisions."

ACIP members agreed there is a likely association between the mRNA Covid-19 vaccines and rare cases of heart inflammation in adolescents and young adults. Almost all the cases resolved with little treatment and patients recovered quickly. The advisers said that the benefits of vaccination outweigh the risks.


The FDA said at the time it would update the fact sheets the reflect the findings.
"The data presented at this meeting reinforced the FDA's decision to revise the fact sheets and further informed the specific revisions," the FDA said in a statement.


Both the FDA and CDC are monitoring reports of these adverse events and will follow up to assess longer-term outcomes, the FDA noted.

Tags : #FDA #CDC #CovidVaccines #MrnaVaccine #HeartInflammation

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

375 Cyclists Gear Up for Health and Fitness at Asian Hospital’s 21KM and 10KM Cycling MarathonMarch 17, 2025
Trapped in the Dopamine Loop: Why You Can’t Stop Scrolling, Eating, or ShoppingMarch 17, 2025
Pig Kidney Transplant Shakes the Medical World: Is This the Future of Organ Donation?March 17, 2025
ENO celebrates Cricket banter in a witty new campaign featuring Aakash GuptaMarch 17, 2025
Advancing Healthcare with Innovation: A Life-Saving Success StoryMarch 17, 2025
MVP Group’s startup accelerator arm IdeaSpace appoints Alwyn Rosel as new Executive Director, succeeds Jay FajardoMarch 17, 2025
SRM Global Hospitals Hosts SPACE 2025 to Advance Electrophysiology and Arrhythmia Treatment in IndiaMarch 17, 2025
The Sleep Crisis in India: Why Rest is Becoming a LuxuryMarch 17, 2025
Managing High Blood Pressure: Importance for Kidney HealthMarch 15, 2025
Teenagers Are Losing Friends While Chasing Perfection: Here’s WhyMarch 13, 2025
Your Desk Job is Destroying Your Mind: Here’s How to Fight BackMarch 13, 2025
Wow! Momo Disrupts FMCG Cup Noodles Market with 'Desi-Asian Flavours' – A First in IndiaMarch 13, 2025
How India’s Kidney Health Crisis is Growing UnnoticedMarch 13, 2025
Stuck Between the Snooze Button and the Hustle: Entrepreneurs Struggle to Get Quality SleepMarch 13, 2025
Can Coffee Keep You Steady on Your Feet? New Study Reveals the TruthMarch 13, 2025
NephroPlus Sets Guinness World Record & India Book of Records Title for Largest Kidney Health Screening DriveMarch 12, 2025
India Choosing to Eat Healthy; Order Volumes Up by 60% for Nutritional ProductsMarch 12, 2025
Amrita students win first prize at DecodeX 2025 hackathonMarch 12, 2025
Why Millions Are Losing Their Sight to Glaucoma And How You Can Prevent ItMarch 12, 2025
Çelebi India Ranks 3rd Worldwide in Ground Handling Performance for Turkish CargoMarch 12, 2025